CorVel Co. (NASDAQ:CRVL) Stock Position Lowered by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC trimmed its position in shares of CorVel Co. (NASDAQ:CRVL) by 6.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,886 shares of the business services provider’s stock after selling 310 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in CorVel were worth $1,597,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its holdings in shares of CorVel by 98.0% during the second quarter. GAMMA Investing LLC now owns 97 shares of the business services provider’s stock worth $25,000 after purchasing an additional 48 shares during the period. Blue Trust Inc. lifted its position in CorVel by 435.3% in the 3rd quarter. Blue Trust Inc. now owns 91 shares of the business services provider’s stock worth $30,000 after buying an additional 74 shares in the last quarter. Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of CorVel during the 3rd quarter valued at $102,000. Benjamin F. Edwards & Company Inc. grew its holdings in shares of CorVel by 130.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 411 shares of the business services provider’s stock valued at $105,000 after acquiring an additional 233 shares in the last quarter. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of CorVel in the third quarter worth $208,000. 51.36% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CorVel

In related news, Director R Judd Jessup sold 2,131 shares of the company’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $295.21, for a total value of $629,092.51. Following the completion of the sale, the director now directly owns 43,277 shares in the company, valued at approximately $12,775,803.17. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, insider Maxim Shishin sold 8,075 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $299.85, for a total value of $2,421,288.75. Following the completion of the sale, the insider now directly owns 1,600 shares in the company, valued at approximately $479,760. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director R Judd Jessup sold 2,131 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $295.21, for a total value of $629,092.51. Following the transaction, the director now owns 43,277 shares in the company, valued at approximately $12,775,803.17. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 16,479 shares of company stock worth $4,978,650 in the last 90 days. 47.57% of the stock is owned by insiders.

CorVel Stock Performance

NASDAQ:CRVL opened at $302.14 on Monday. The company has a market capitalization of $5.18 billion, a P/E ratio of 66.99 and a beta of 1.10. The stock’s 50 day moving average price is $312.48 and its 200 day moving average price is $283.23. CorVel Co. has a 52 week low of $194.85 and a 52 week high of $329.23.

Analysts Set New Price Targets

Separately, StockNews.com cut CorVel from a “buy” rating to a “hold” rating in a research report on Saturday, August 31st.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.